MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$14,275K
Free Cash flow
$46,532K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from the maturities of ...
    • Accrued expenses, accrued collab...
    • Proceeds from issuance of class ...
    • Others
Negative Cash Flow Breakdown
    • Purchases of short-term investme...
    • Prepaid expenses and other curre...
    • Accounts payable
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
25,432
22,592
14,199
18,435
Depreciation and amortization expense
472
468
467
384
Share-based compensation expense
11,636
10,056
10,235
10,144
Non-cash lease expense
1,011
994
963
944
Net amortization of premiums and accretion of discounts on short-term investments
-93
-1,302
930
-603
Net gain on disposal of property and equipment
-22
54
53
43
Deferred income taxes
2,661
4,523
3,138
4,227
Prepaid expenses and other current assets
18,572
-13,049
12,316
-2,030
Accounts receivable, net
266
7,630
-36,148
19,832
Inventory
-2,211
18,246
13,499
-6,785
Other long-term assets
-249
-125
3,042
143
Accounts payable
-11,999
22,266
-4,122
-2,728
Accrued expenses, accrued collaboration expenses and other current liabilities
25,791
-5,047
19,627
8,368
Operating lease liabilities
-158
-993
-918
-760
Other long-term liabilities
8,612
6,794
3,997
5,263
Net cash provided by operating activities
47,195
50,199
53,894
33,677
Purchases of property and equipment
663
161
633
671
Purchases of short-term investments
109,620
177,411
110,962
146,160
Proceeds from the maturities of short-term investments
36,703
145,656
40,781
84,076
Net cash used in investing activities
-73,580
-31,916
-70,814
-62,755
Proceeds from issuance of class a ordinary shares under incentive award plans and employee share purchase plan
17,578
6,389
8,576
16,252
Payments in connection with ordinary shares tendered for employee tax obligations
5,468
316
918
4,353
Net cash provided by financing activities
12,110
6,073
7,658
11,899
Net increase in cash and cash equivalents
-14,275
24,356
-9,262
-17,179
Cash and cash equivalents at beginning of period
189,952
165,596
174,858
183,581
Cash and cash equivalents at end of period
175,677
189,952
165,596
174,858
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accrued expenses,accrued collaboration...$25,791K (171.43%↑ Y/Y)Net income$25,432K (-3.56%↓ Y/Y)Proceeds from issuance ofclass a ordinary...$17,578K (10.38%↑ Y/Y)Share-based compensationexpense$11,636K (-30.00%↓ Y/Y)Other long-termliabilities$8,612K (15.77%↑ Y/Y)Deferred income taxes$2,661K (-52.79%↓ Y/Y)Inventory-$2,211K (-110.13%↓ Y/Y)Non-cash lease expense$1,011K (-42.52%↓ Y/Y)Depreciation andamortization expense$472K (-32.86%↓ Y/Y)Other long-termassets-$249K (87.39%↑ Y/Y)Net amortization ofpremiums and accretion of...-$93K (-115.79%↓ Y/Y)Net gain on disposalof property and...-$22K (-191.67%↓ Y/Y)Net cash provided byoperating activities$47,195K (-6.39%↓ Y/Y)Net cash provided byfinancing activities$12,110K (-10.07%↓ Y/Y)Canceled cashflow$30,995K Canceled cashflow$5,468K Net increase in cashand cash...-$14,275K (-268.82%↓ Y/Y)Canceled cashflow$59,305K Proceeds from thematurities of short-term...$36,703K (-50.82%↓ Y/Y)Prepaid expenses andother current assets$18,572K (52.29%↑ Y/Y)Accounts payable-$11,999K (-271.61%↓ Y/Y)Accounts receivable, net$266K (102.71%↑ Y/Y)Operating leaseliabilities-$158K (91.11%↑ Y/Y)Payments in connectionwith ordinary shares...$5,468K (122.37%↑ Y/Y)Net cash used ininvesting activities-$73,580K (-32.76%↓ Y/Y)Canceled cashflow$36,703K Purchases of short-terminvestments$109,620K (-15.54%↓ Y/Y)Purchases of property andequipment$663K (151.14%↑ Y/Y)

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA)